Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

EUTHROID-0.5

LIOTRIX (T4;T3)

Standard Dose
0.03MG;0.0075MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview EUTHROID-0.5 is listed in Drugs@FDA under application 016680 (NDA).

Marketing status: Discontinued Active ingredient LIOTRIX (T4;T3) Form and strength TABLET;ORAL - 0.03MG;0.0075MG Sponsor PARKE DAVIS Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview EUTHROID-0.5 is listed in Drugs@FDA under application 016680 (NDA). Marketing status: Discontinued Active ingredient LIOTRIX (T4;T3) Form and strength TABLET;ORAL - 0.03MG;0.0075MG Sponsor PARKE DAVIS Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.